1. Jordan KM, Arden NK, Doherty M et al. EULAR Recommendations 2003: anevidence based approach to the management of knee osteoarthritis: Report or a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESTISIT). Ann Rheum Dis 2003; 62: 1145–55.
2. Беленький А.Г. Препараты гиалуроновой кислоты в лечении остеоартроза. М., 2005.
3. Лила А.М. Остеоартроз коленных суставов: лечение с позиций доказательной медицины. Новые Санкт-Петербургские врачебные ведомости. 2006; 1 (35): 38–44.
4. Laurent TC, Laurent UB, Fraser JR. The structure and function of hyaluronan: An overview. Immunol Cell Biol 1996; 74 (2): 1–7.
5. Ward PD, Thibeault SL, Gray SD. Hyaluronic acid: its role in voice. J Voice 2002; 16 (3): 303–9.
6. Wobig M, Dickhut A, Maier R, Vetter G. Viscosupplementation with hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee. Clin Ther 1998; 20 (20): 410–23.
7. Belenkiy A, Denisov L, Lila A et al. Comparative efficacy of three and five intra-articular injections of sodium hyaluronate (Ostenil) in the treatment of knee osteoarthritis – a 12-month study. Ann Rheum Dis 2006; 65 (Suppl. II): 223.
8. Sandell LJ, Aigner T. Articular cartilage and changes in arthritis. An introduction: cell biology of osteoarthritis. Arthritis Res 2001; 3: 107–13.
9. Pelletier JP, Martel-Pelletier J, Abramson SB. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum 2001; 44: 1237–47.
10. Tanimoto K, Ohno S, Fujimoto K et al. Proinflammatory cytokines regulate the gene expression of hyaluronic acid synthetase in cultured rabbit synovial membrane cells. Connect Tissue Res 2001; 42: 187–95.
11. Knudson W, Loeser RF. CD44 and integrin matrix receptors participate in cartilage homeostasis. Cel Mol Life Sci 2002; 59: 36–44.
12. Aihara S, Murakami N, Ishii R et al. Effects of sodium hyaluronate on the nociceptive response of rats with experimentally induced arthritis. Nip Yakur Zasshi 1992; 100: 359–65.
13. Moore AR, Willoughby DA. Hyaluronan as a drug delivery system for diclofenac: a hypothesis for mode of action. Int J Tissue React 1995; 17: 153–6.
14. Dougados M, Nguyen M, Listrat V, Amor B. High molecular weight sodium hyaluronate (hyalectin) in osteoarhtritis of the knee: a 1 year placebo controlled trial. Osteoarthritis Cartilage 1993; 21: 97–103.
15. Listrat V, Ayral X, Patarnello F et al. Arthroscopic evaluation of potential structure modifyting activity of hyaluronan (Hyalgan) in osteoarthritis of the knee. Osteoarthritis Cartilage 1997; 5: 153–60.
16. Lussier A, Cividino AA, McFarlane CA et al. Viscosupplementation with Hylan for the treatment of osteoarthritis findings from clinical practice in Canada. J Rheumatol 1996; 23 (1): 579–85.
17. Lahmander LS, Dalen N, Englund G. Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomized, double blind, placebo-controlled multicentre trial. Ann Rheum Dis 1996; 55: 424–31.
18. Stove J, Puhl W. Overview of clinical and experimental use of hyaluronic acid in gonarthrosis. Z Orthop Ihre Grenzgeb 1999; 137 (5): 393–9.
19. Belcher C, Yaqub R, Fawthrop F et al. Synovial fluid chondroitin and keratan sulphate epitopes, glycosaminoglycans, and hyaluronan in arthritic and normal knees. Ann Rheum Dis 1997; 56: 299–307.
20. Conrozier T, Vignon E. Is there evidence to support the inclusion of viscosupplementation in the treatment paradigm for patients with hip osteoarthritis. Clin Exp Rheumatol 2005; 23 (5): 711–6.
21. Puttick MP, Wade JP, Chalmers A et al. Acute local reactions after intraarticular hylan for osteoarthritis of the knee. J Rheumatol 1996; 23 (5): 945–6.
22. Kirvan J. Is there a place for intra-articular hyaluronate in osteoarthritis of the knee? Knee 2001; 8: 93–101.
23. Henderson EB, Smith EC, Pegley F, Blake DR. Intra-articular injections of 750 kD hyaluronan in the treatment of osteoarthritis: a randomised single centre double-blind placebo-controlled trial of 91 patients demonstrating lack of efficacy. J Rheumatol 1996; 23 (5): 944–5.
24. Tikiz C, Unlu Z, Sener A, Efe M. Comparison of the efficacy of lower and higher molecular weight viscosupplementation in the treatment of hip osteoarthritis. Clin Rheumathol 2005; 24: 244–50.
25. Tortorella MD, Malfait AM, Deccico C, Arner E. The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation. Osteoarthritis Cartilage 2001; 9: 539–52.